What is the prevalence of Pheochromocytoma?

Pheochromocytoma is a rare neuroendocrine tumor with an estimated annual incidence of 2 to 8 cases per million people in the general population. While often categorized as a rare disease, the true prevalence of Pheochromocytoma remains challenging to quantify due to high rates of asymptomatic cases and post-mortem findings, with autopsy studies suggesting the condition may be more common than clinical diagnoses indicate.

What is the estimated incidence and prevalence of Pheochromocytoma?

The clinical incidence of Pheochromocytoma is generally cited as 0.8 per 100,000 person-years. However, clinical data often underestimate the true frequency. Autopsy studies have historically reported a prevalence of roughly 1 in 2,000, suggesting that many individuals harbor Pheochromocytoma tumors that never cause symptoms or are never clinically identified during their lifetime. Because it is a tumor of the adrenal medulla, it is categorized as a rare disease by international health authorities.

Is there a specific age or gender distribution for Pheochromocytoma?

Pheochromocytoma can occur at any age, but it is most frequently diagnosed in adults between the ages of 30 and 50 years. While it is rare in children, pediatric cases are more likely to be associated with underlying genetic syndromes. Current medical literature indicates that Pheochromocytoma affects males and females with roughly equal frequency, showing no significant gender predilection in the general population. There are no consistent geographic or ethnic variations identified in the prevalence of the condition, though genetic clusters may appear in specific populations due to inherited mutations.

Why is accurate data on Pheochromocytoma prevalence difficult to obtain?

Obtaining precise epidemiological data for Pheochromocytoma is complicated by several factors:

• Asymptomatic presentation: Many tumors are incidental findings during imaging scans performed for unrelated medical issues.


• Diagnostic delay: The "great mimic" nature of the disease means symptoms like hypertension are often attributed to common cardiovascular conditions, leading to significant underdiagnosis.


• Genetic screening: As genetic testing becomes more accessible, we are identifying more cases linked to hereditary syndromes (such as VHL, MEN2, or NF1), which shifts our understanding of population-level prevalence.

How does the DiseaseMaps.org community perspective compare?

While formal clinical registries provide the foundation for our understanding, the DiseaseMaps.org platform offers a vital real-world perspective. Currently, 165 people with Pheochromocytoma have joined our community to share their personal journeys. This data highlights the patient experience behind the statistics, emphasizing the time-to-diagnosis gap that many patients face. Engaging with this community allows researchers and clinicians to better understand the lived reality of those navigating this rare condition, moving beyond simple incidence rates to include patient-reported outcomes and diagnostic challenges.

Next steps

• Consult an endocrinologist or a specialist in neuroendocrine tumors if you have symptoms of paroxysmal hypertension, headaches, or palpitations.


• Speak with a genetic counselor to determine if genetic testing for hereditary syndromes is appropriate for your specific case.


• Connect with the 165 members of the DiseaseMaps.org community to share experiences and gain support from others navigating a Pheochromocytoma diagnosis.


• Request a referral to a high-volume center of excellence that specializes in the surgical and medical management of adrenal tumors.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH GARD (Genetic and Rare Diseases Information Center): Information on Pheochromocytoma incidence and clinical features.


• Orphanet: Rare disease database providing prevalence estimates for Pheochromocytoma and Paraganglioma.


• OMIM (Online Mendelian Inheritance in Man): Genetic data regarding the hereditary nature of Pheochromocytoma.


• PubMed/NCBI: Systematic reviews on the epidemiology and diagnostic challenges of adrenal neuroendocrine tumors.